Press release
HIV Diagnostics Market Set to Boom Anticipating Explosive 7.6% CAGR Growth Surpass US$ 5,396.32 Million Forecast by 2025 to 2034
HIV Diagnostics Market
Market Scope:
Acquired immunodeficiency syndrome (AIDS), is a consistent chronic condition. It is developed by the human immunodeficiency virus, also known as HIV. HIV injures the immune system, so the body fails to combat the infection and disease. If HIV is not cured; over the years, it weakens the immune system enough to become AIDS. It can be detected through blood and saliva testing.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/hiv-diagnostics-market/request-for-sample
The antigen/antibody test frequently uses blood-based diagnostics. The immune system assembles antibodies when subjected to HIV. Antibodies appear in the blood only after weeks and months. In antibody tests, the blood and saliva of the patient are tested for. This includes self-tests done domestically. The positive outcomes appear only after 3 to 12 weeks subsequently being subjected to HIV.
Market Drivers:
Growing Rate of HIV Contamination:
The growing rate of HIV contamination cases, especially in low- and middle-income countries (LMICs), is notably driving the market growth by pushing the demand for HIV screening procedures, early detection, and confirmatory testing solutions. In 2022, roughly 31,800 persons were lately contaminated with HIV in the US. In the course of the same year, the aggregate of HIV diagnoses amongst patients aged 13 and older touched 37981 across the US, spiraling the HIV diagnostics market upwards.
Rising Funding by Governments and NGOs:
Funding by governments, the World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), and non-profits are playing a pivotal role in market development. These fundings are increasing access to cost-effective, elevated quality testing solutions in restrictive settings.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/hiv-diagnostics-market/request-for-discount-pricing
Competitive Landscape:
The key contenders of the market are using several strategies, such as product advancements, joint ventures, and technology integration, to acquire a notable market share.
The following are the key players analyzed in the report:
• Abbott
• Apogee Flow Systems
• Beckman Coulter, Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
• Janssen Global Services, LLC
• Merck & Co. Inc.
• Mylan N.V.
• QIAGEN.
• Siemens Healthcare GmbH
• Sysmex Europe SE
• VIIV Healthcare
HIV Diagnostics Market Report Highlights:
• In terms of product, the consumables segment dominated the HIV diagnostics market share in 2024 due to the high demand for reagents, test kits, and assay consumables across diagnostic laboratories.
• Based on end use, the diagnostic laboratories segment accounted for the largest market share in 2024 due to the widespread adoption of advanced HIV diagnostic technologies and centralized testing models.
• In 2024, North America accounted for the largest market share due to high testing rates and well-established healthcare infrastructure.
• Asia Pacific is expected to register the highest CAGR during the forecast period due to increasing awareness initiatives, expansion of ART coverage, and technological advancements.
Market Segmentation:
By Product Outlook (Revenue, USD Million, 2020-2034)
• Consumables
• Instruments
• Software and Services
By Mode Outlook (Revenue, USD Million, 2020-2034)
• Self-Test
• Lab-Based
By Test Type Outlook (Revenue, USD Million, 2020-2034)
• Antibody Test
• HIV-1 Screening Tests
• HIV-1 Antibody Confirmatory Tests
• HIV-2 & Group O Diagnostic Tests
• Viral Load Test
• CD4 Test
• Others
By End Use Outlook (Revenue, USD Million, 2020-2034)
• Diagnostic Laboratories
• Hospitals & Clinics
• Home Settings
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/hiv-diagnostics-market
Geographical Landscape:
The HIV diagnostics market report offers detailed insights into the market landscape, which is further categorized into sub-regions and specific countries.
North America accounted for the largest share in 2024 due to elevated testing rates, entrenched healthcare frameworks, and robust government-supported HIV screening enterprises.
Asia Pacific is anticipated to witness the highest CAGR due to the growing HIV prevalence, escalated government-supported testing programs, and rising funding in healthcare framework.
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
More Trending Latest Reports by Polaris Market Research:
Photoacoustic Tomography Market:
https://www.polarismarketresearch.com/industry-analysis/photoacoustic-tomography-market
Memory-Augmenting Neural Devices Market:
https://www.polarismarketresearch.com/industry-analysis/memory-augmenting-neural-devices-market
Asia Pacific Radiopharmaceuticals Market:
https://www.polarismarketresearch.com/industry-analysis/asia-pacific-radiopharmaceuticals-market
Joint Replacement Devices Market:
https://www.polarismarketresearch.com/industry-analysis/joint-replacement-devices-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Diagnostics Market Set to Boom Anticipating Explosive 7.6% CAGR Growth Surpass US$ 5,396.32 Million Forecast by 2025 to 2034 here
News-ID: 3984027 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
